NasdaqCM - Nasdaq Real Time Price USD

iCAD, Inc. (ICAD)

1.4800 -0.0800 (-5.13%)
At close: April 25 at 4:00 PM EDT
1.4900 +0.01 (+0.68%)
After hours: April 25 at 7:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
17,318.0000
17,318.0000
19,802.0000
33,638.0000
29,698.0000
Cost of Revenue
2,533.0000
2,533.0000
2,983.0000
9,395.0000
8,344.0000
Gross Profit
14,785.0000
14,785.0000
16,819.0000
24,243.0000
21,354.0000
Operating Expense
22,474.0000
22,474.0000
27,017.0000
34,975.0000
30,742.0000
Operating Income
-7,689.0000
-7,689.0000
-10,198.0000
-10,732.0000
-9,388.0000
Net Non Operating Interest Income Expense
713.0000
713.0000
203.0000
-126.0000
-379.0000
Other Income Expense
-14.0000
-14.0000
-39.0000
-386.0000
-7,805.0000
Pretax Income
-6,990.0000
-6,990.0000
-10,034.0000
-11,244.0000
-17,572.0000
Tax Provision
20.0000
20.0000
-116.0000
1.0000
38.0000
Net Income Common Stockholders
-4,847.0000
-4,847.0000
-13,656.0000
-11,245.0000
-17,610.0000
Diluted NI Available to Com Stockholders
-4,847.0000
-4,847.0000
-13,656.0000
-11,245.0000
-17,610.0000
Basic EPS
-0.39
-0.19
-0.54
-0.45
-0.80
Diluted EPS
-0.39
-0.19
-0.54
-0.45
-0.80
Basic Average Shares
25,345.2500
25,613.0000
25,202.0000
24,778.0000
22,140.0000
Diluted Average Shares
25,345.2500
25,613.0000
25,202.0000
24,778.0000
22,140.0000
Total Operating Income as Reported
-7,689.0000
-7,689.0000
-10,198.0000
-10,732.0000
-9,388.0000
Total Expenses
25,007.0000
25,007.0000
30,000.0000
44,370.0000
39,086.0000
Net Income from Continuing & Discontinued Operation
-4,847.0000
-4,847.0000
-13,656.0000
-11,245.0000
-17,610.0000
Normalized Income
-7,010.0000
-7,010.0000
-9,918.0000
-10,963.2200
-17,361.0700
Interest Income
729.0000
729.0000
213.0000
15.0000
97.0000
Interest Expense
16.0000
16.0000
10.0000
141.0000
476.0000
Net Interest Income
713.0000
713.0000
203.0000
-126.0000
-379.0000
EBIT
-6,974.0000
-6,974.0000
-10,024.0000
-11,103.0000
-17,096.0000
EBITDA
-6,565.0000
-6,565.0000
-9,503.0000
-10,546.0000
-16,519.0000
Reconciled Cost of Revenue
2,373.0000
2,373.0000
2,679.0000
9,078.0000
7,966.0000
Reconciled Depreciation
409.0000
409.0000
521.0000
557.0000
577.0000
Net Income from Continuing Operation Net Minority Interest
-7,010.0000
-7,010.0000
-9,918.0000
-11,245.0000
-17,610.0000
Total Unusual Items Excluding Goodwill
--
--
--
-386.0000
-341.0000
Total Unusual Items
--
--
--
-386.0000
-341.0000
Normalized EBITDA
-6,565.0000
-6,565.0000
-9,503.0000
-10,160.0000
-16,178.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
-104.2200
-92.0700
12/31/2020 - 12/13/1984

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDAI Spectral AI, Inc.
1.8400
-0.54%
 
PROF Profound Medical Corp.
8.03
+2.95%
 
IRMD IRADIMED CORPORATION
41.47
-2.29%
 
CERS Cerus Corporation
1.7000
+2.41%
 
IRIX IRIDEX Corporation
2.9600
+0.68%
 
LUNG Pulmonx Corporation
7.30
-2.93%
 
MXCT MaxCyte, Inc.
3.6900
-1.34%
 
MODD Modular Medical, Inc.
1.5000
-5.06%
 
QIPT Quipt Home Medical Corp.
3.6600
-4.69%
 
MASS 908 Devices Inc.
5.56
-1.07%